As filed with the Securities and Exchange Commission on April 20, 2026
Registration No. 333-294697
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
FORM S-1
REGISTRATION STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
Alamar Biosciences, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
| Delaware |
|
3826 |
|
36-4899036 |
| (State or other jurisdiction of
incorporation organization) |
|
(Primary Standard Industrial
Classification Code Number) |
|
(I.R.S. Employer
Identification No.) |
47071 Bayside Parkway
Fremont, California 94538
(510) 626-9888
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Yuling Luo, Ph.D.
Founder, Chairman and Chief Executive Officer
Alamar Biosciences, Inc.
47071 Bayside Parkway
Fremont, California 94538
(510) 626-9888
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
|
|
|
| Kristin VanderPas
Charles S. Kim Dave
Peinsipp Cooley LLP
3 Embarcadero Center 20th
Floor San Francisco, California 94111
(415) 693-2000 |
|
Nathan Ajiashvili
Ross McAloon B. Shayne
Kennedy Latham & Watkins LLP
1271 Avenue of the Americas
New York, New York 10020
(212) 906-1200 |
Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration
statement.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415
under the Securities Act of 1933, please check the following box: ☐
If this Form is filed to register additional securities
for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this
Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. ☒
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting
company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
|
|
|
|
|
|
|
| Large accelerated filer |
|
☐ |
|
Accelerated filer |
|
☐ |
|
|
|
|
| Non-accelerated filer |
|
☒ |
|
Smaller reporting company |
|
☒ |
|
|
|
|
|
|
|
|
Emerging growth company |
|
☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
This registration statement shall become effective upon filing with the U.S. Securities and Exchange Commission in accordance with Rule
462(d) promulgated under the Securities Act of 1933, as amended.
